Bionano Genomics (BNGO) Interest Expenses (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Interest Expenses data on file, last reported at $6.2 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 661.27% year-over-year to $6.2 million; the trailing twelve-month figure through Mar 2026 stood at $6.2 million (down 34.12% YoY), and the FY2025 full-year result was $2.4 million, down 77.38% from the prior year.
• Interest Expenses advanced to $6.2 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $8.4 million in Q1 2023 to a low of $75000.0 in Q4 2022.
• A 5-year average of $4.7 million and a median of $6.2 million in 2026 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 4698.86% in 2023 and plunged 85.48% in 2025, its largest moves.
• Tracing BNGO's Interest Expenses over 5 years: stood at $75000.0 in 2022, then soared by 3053.33% to $2.4 million in 2023, then slumped by 73.45% to $628000.0 in 2024, then soared by 74.84% to $1.1 million in 2025, then soared by 465.76% to $6.2 million in 2026.
• Business Quant data shows BNGO's Interest Expenses at $6.2 million in Q1 2026, $1.1 million in Q4 2025, and $4.8 million in Q3 2025.